filmov
tv
IBS-D: Therapeutic Advances and the Impact of the Gut Microbiome

Показать описание
This webcast features presentations that provide an understanding of the mechanisms-of-action, clinical evidence, and cost utility data surrounding pharmacotherapies indicated for IBS-D treatment to informed clinical and formulary discussions.
IBS-D: Therapeutic Advances and the Impact of the Gut Microbiome
All About IBS-D
IBS-D: Pathophysiology and Treatment
Expert Perspectives: Targeting the Etiology of IBS-D with Emerging Therapies
Case #2: Diagnosing and managing motility disorders in IBS-D
Case #1: Diagnosing and Managing Bacterial Disturbances in IBS-D
An Exploration of Advances in the Diagnosis and Management of IBS and CIC
Understanding IBS-D Webinar
Best Practices in the Management of Irritable Bowel Syndrome (IBS)
CDHF Talks IBS and the Gut Microbiome Part 7: Medications for IBS
Approaching IBS-D Management: 5-HT3 Directed Therapy
Pharmacologic Approach to IBS: Beyond Diet and Fiber
CDHF Talks IBS and the Gut Microbiome Part 2: Subtypes of IBS
Stratifying Patients With IBS-C to the Appropriate Agent
Irritable bowel syndrome (IBS) cause, symptoms and treatment
Use of Eluxadoline in IBS-D
What are the latest advances in the treatment of IBS-Constipation?
Updates in Pharmacological Therapy for IBS
All About IBS-C
What are the latest advances in managing gut health in IBS-Constipation?
Recent Advances in GERD & IBS Management
Keeping Up with IBS Treatment Strategies
Irritable Bowel Syndrome: An Overview
Living with and managing irritable bowel syndrome with diarrhea
Комментарии